NeuroSense Therapeutics Ltd. Warrant (NRSNW) Key Ratios
$0.05
As on 02-Sep-2026 15:55EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 0.00 | -- | -86.05 | -7.76 | -213.67 |
| Net Profit | 0.00 | -78.12 | -8.96 | 3.18 | -214.10 |
| EPS | 0.00 | -61.88 | 25.30 | 16.90 | 2.71 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-25 | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -1,725.60 | -1,085.84 | -2,174.98 | -2,478.16 | -523.68 |
| Return on Capital
| -1,400.89 | -884.22 | -1,757.50 | -1,965.35 | -479.80 |
| Return on Assets
| -281.93 | -208.18 | -397.11 | -263.14 | -185.53 |
| Debt to Equity (x)
| -- | -- | -0.11 | 0.03 | -0.08 |
The underlying data is unavailable.